Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
Condition(s):Substance-Related DisordersLast Updated:January 12, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Substance-Related DisordersLast Updated:January 12, 2018Completed
Condition(s):Multiple Myeloma; First RelapseLast Updated:February 12, 2024Not yet recruiting
Condition(s):Multiple Sclerosis, Relapsing-RemittingLast Updated:September 13, 2023Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:February 20, 2020Completed
Condition(s):Relapse; Cognitive Impairment; DepressionLast Updated:November 29, 2019Unknown status
Condition(s):Allograft; Post-allograft RelapseLast Updated:March 4, 2024Terminated
Condition(s):Smoking CessationLast Updated:August 17, 2021Completed
Condition(s):Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis RelapseLast Updated:February 1, 2022Completed
Condition(s):Opioid-use Disorder; Opioid Abuse, in Remission; Alcohol Use Disorder; Alcohol Use Disorder, in RemissionLast Updated:March 8, 2024Completed
Condition(s):Opioid Use Disorder; RelapseLast Updated:September 6, 2023Enrolling by invitation
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.